Nebilet (Nebivolol)

Nebivolol, the active ingredient in Nebilet, is a beta blocker presented as an oral tablet for oral use. It helps lower blood pressure and improve heart function in adults with hypertension or heart failure.

GNH USA supplies Nebilet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebilet is a selective β1‑adrenergic blocker used in cardiovascular disease management.

- Hypertension: lowers systolic and diastolic blood pressure in adults. - Heart failure: improves cardiac output and reduces symptoms of reduced‑ejection‑fraction heart failure. - Elderly patients with hypertension: provides effective blood‑pressure control with a favorable metabolic profile.

Nebilet may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Fatigue: feeling of tiredness or reduced energy. - Dizziness: light‑headed sensation, especially on standing. - Bradycardia: slower than normal heart rate. - Nasal congestion: blocked or runny nose. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe bradycardia: markedly slow heart rate requiring medical attention. - Hypotension: significant drop in blood pressure leading to fainting. - Heart block: impairment of electrical conduction in the heart. - Bronchospasm: narrowing of airways, especially in patients with asthma. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzymes or liver injury.

Before initiating Nebilet, clinicians should evaluate patient‑specific factors and monitor therapy.

- Cardiovascular assessment: monitor heart rate and blood pressure regularly. - Respiratory conditions: use cautiously in patients with asthma or chronic obstructive pulmonary disease. - Renal impairment: consider dose adjustment in moderate to severe renal dysfunction. - Drug interactions: review concomitant medications for potential additive effects. - Pregnancy and lactation: safety not established; avoid unless benefits outweigh risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Nebilet can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Non‑selective beta‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): risk of severe bradycardia. - Clonidine abrupt withdrawal: may precipitate rebound hypertension.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance hypotensive effect. - Diuretics: increase risk of orthostatic hypotension. - Antidiabetic agents: may mask hypoglycemia symptoms.